Brentuximab vedotin and Insulin Degludec (U-100) Vials
Determining the interaction of Brentuximab vedotin and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brentuximab
Brand name: Adcetris
Synonyms: Brentuximab Vedotin
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brentuximab vedotin-Insulin Degludec (U-200) Prefilled Pens
- Brentuximab vedotin-Insulin degludec and liraglutide
- Brentuximab vedotin-Insulin degludec and liraglutide Subcutaneous
- Brentuximab vedotin-Insulin degludec Subcutaneous
- Brentuximab vedotin-Insulin detemir
- Brentuximab vedotin-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Breo Ellipta
- Insulin Degludec (U-100) Vials-Brethine
- Insulin Degludec (U-100) Vials-Brethine Subcutaneous
- Insulin Degludec (U-100) Vials-Bretylium
- Insulin Degludec (U-100) Vials-Bretylium Injection
- Insulin Degludec (U-100) Vials-Brevibloc